CN101977925B - 优化的粘附素片段及相应的纳米颗粒 - Google Patents
优化的粘附素片段及相应的纳米颗粒 Download PDFInfo
- Publication number
- CN101977925B CN101977925B CN200880128223.9A CN200880128223A CN101977925B CN 101977925 B CN101977925 B CN 101977925B CN 200880128223 A CN200880128223 A CN 200880128223A CN 101977925 B CN101977925 B CN 101977925B
- Authority
- CN
- China
- Prior art keywords
- adhesin
- nano particle
- cea
- order
- hitting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
Abstract
Description
BSA溶液30% | 106.4 |
匀浆物 | 213.6 |
戊二醛溶液25% | 17.0 |
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08003845.8 | 2008-02-29 | ||
EP08003845 | 2008-02-29 | ||
PCT/EP2008/004867 WO2009106102A1 (de) | 2008-02-29 | 2008-06-17 | Optimierte adhäsin-fragmente und entsprechende nanopartikel |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101977925A CN101977925A (zh) | 2011-02-16 |
CN101977925B true CN101977925B (zh) | 2014-11-05 |
Family
ID=39967419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880128223.9A Expired - Fee Related CN101977925B (zh) | 2008-02-29 | 2008-06-17 | 优化的粘附素片段及相应的纳米颗粒 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8796200B2 (zh) |
EP (1) | EP2250190B1 (zh) |
JP (1) | JP5552437B2 (zh) |
KR (1) | KR101557982B1 (zh) |
CN (1) | CN101977925B (zh) |
AT (1) | ATE552268T1 (zh) |
AU (1) | AU2008351621B2 (zh) |
BR (1) | BRPI0822328A2 (zh) |
CA (1) | CA2716648A1 (zh) |
DK (1) | DK2250190T3 (zh) |
ES (1) | ES2392089T3 (zh) |
HK (1) | HK1153211A1 (zh) |
IL (1) | IL207839A0 (zh) |
MX (1) | MX2010009526A (zh) |
NZ (1) | NZ587438A (zh) |
PL (1) | PL2250190T3 (zh) |
RU (1) | RU2010139903A (zh) |
WO (1) | WO2009106102A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103041407B (zh) * | 2012-12-19 | 2015-02-18 | 深圳先进技术研究院 | 核-壳型纳米造影剂、其制备方法及应用 |
EP2886126B1 (en) | 2013-12-23 | 2017-06-07 | Exchange Imaging Technologies GmbH | Nanoparticle conjugated to CD44 binding peptides |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1717417A (zh) * | 2001-10-26 | 2006-01-04 | 行星生物技术有限公司 | 用于治疗和预防毒性及病原体介导的疾病的新的免疫粘附素 |
WO2007057182A2 (de) * | 2005-11-16 | 2007-05-24 | Signalomics Gmbh | Fluoreszenz-nanopartikel |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9317423D0 (en) * | 1993-08-21 | 1993-10-06 | Imp Cancer Res Tech | Monoclonal antibodies |
US6179912B1 (en) * | 1999-12-20 | 2001-01-30 | Biocrystal Ltd. | Continuous flow process for production of semiconductor nanocrystals |
US7205048B2 (en) | 2001-09-17 | 2007-04-17 | Invitrogen Corporation | Functionalized fluorescent nanocrystal compositions and methods of making |
JP4512364B2 (ja) | 2001-10-02 | 2010-07-28 | ライフ テクノロジーズ コーポレーション | 半導体ナノ粒子合成方法 |
DE60334112D1 (de) | 2002-06-27 | 2010-10-21 | Georgia Tech Res Inst | Optische fluoreszenzmarkierungen im nanomassstab und verwendungen davon |
EP2530719B1 (en) | 2003-05-07 | 2020-08-05 | Indiana University Research and Technology Corporation | Alloyed semiconductor concentration-gradient quantum dots, use and method of fabricating thereof |
EP1721974B1 (de) | 2005-05-04 | 2008-10-15 | Signalomics GmbH | Kompetitives n-Hybrid System |
EP1777292A1 (de) | 2005-10-19 | 2007-04-25 | Signalomics GmbH | Verfahren zum Erzeugen von genetischer Diversität in vivo |
WO2008074461A2 (de) | 2006-12-18 | 2008-06-26 | Signalomics Gmbh | Fluoreszenz-nanopartikel |
WO2009045579A2 (en) * | 2007-06-14 | 2009-04-09 | The Regents Of The University Of California | Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
-
2008
- 2008-06-17 KR KR1020107021444A patent/KR101557982B1/ko active IP Right Grant
- 2008-06-17 BR BRPI0822328-9A patent/BRPI0822328A2/pt not_active IP Right Cessation
- 2008-06-17 ES ES08784517T patent/ES2392089T3/es active Active
- 2008-06-17 PL PL08784517T patent/PL2250190T3/pl unknown
- 2008-06-17 AU AU2008351621A patent/AU2008351621B2/en not_active Expired - Fee Related
- 2008-06-17 JP JP2010547961A patent/JP5552437B2/ja not_active Expired - Fee Related
- 2008-06-17 RU RU2010139903/10A patent/RU2010139903A/ru not_active Application Discontinuation
- 2008-06-17 US US12/920,236 patent/US8796200B2/en not_active Expired - Fee Related
- 2008-06-17 DK DK08784517.8T patent/DK2250190T3/da active
- 2008-06-17 MX MX2010009526A patent/MX2010009526A/es active IP Right Grant
- 2008-06-17 CA CA2716648A patent/CA2716648A1/en not_active Abandoned
- 2008-06-17 WO PCT/EP2008/004867 patent/WO2009106102A1/de active Application Filing
- 2008-06-17 CN CN200880128223.9A patent/CN101977925B/zh not_active Expired - Fee Related
- 2008-06-17 AT AT08784517T patent/ATE552268T1/de active
- 2008-06-17 NZ NZ587438A patent/NZ587438A/en not_active IP Right Cessation
- 2008-06-17 EP EP08784517A patent/EP2250190B1/de not_active Not-in-force
-
2010
- 2010-08-26 IL IL207839A patent/IL207839A0/en unknown
-
2011
- 2011-07-19 HK HK11107481.8A patent/HK1153211A1/zh not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1717417A (zh) * | 2001-10-26 | 2006-01-04 | 行星生物技术有限公司 | 用于治疗和预防毒性及病原体介导的疾病的新的免疫粘附素 |
WO2007057182A2 (de) * | 2005-11-16 | 2007-05-24 | Signalomics Gmbh | Fluoreszenz-nanopartikel |
Non-Patent Citations (10)
Title |
---|
A Subfamily of Dr Adhesins of Escherichia coli Bind Independently to Decay-accelerating Factor and the N-domain of Carcinoembryonic Antigen;Natalia Korotkova等;《JOURNAL OF BIOLOGICAL CHEMISTRY》;20060929;第281卷(第39期);29120–29130 * |
Cedric N. Berger等.Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering.《Molecular Microbiology》.2007,第52卷(第4期),963-983. * |
Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering;Cedric N. Berger等;《Molecular Microbiology》;20071231;第52卷(第4期);963-983 * |
Identification of amino acids in Dr adhesin required for binding to decay-accelerating factor;van Loy等;《Molecular Microbiology》;20021231;第45卷(第2期);439-452 * |
In vivo cancer targeting and imaging with semiconductor quantum dots;Xiaohu Gao等;《Nature Biotechnology》;20040830;969-976 * |
Natalia Korotkova等.A Subfamily of Dr Adhesins of Escherichia coli Bind Independently to Decay-accelerating Factor and the N-domain of Carcinoembryonic Antigen.《JOURNAL OF BIOLOGICAL CHEMISTRY》.2006,第281卷(第39期),29120–29130. * |
Natalia Korotkova等.Selection for functional diversity drives accumulation of point mutations in Dr adhesins of Escherichia coli.《Molecular Microbiology》.2007,第64卷(第1期),180–194. * |
Selection for functional diversity drives accumulation of point mutations in Dr adhesins of Escherichia coli;Natalia Korotkova等;《Molecular Microbiology》;20071231;第64卷(第1期);180–194 * |
van Loy等.Identification of amino acids in Dr adhesin required for binding to decay-accelerating factor.《Molecular Microbiology》.2002,第45卷(第2期),439-452. * |
Xiaohu Gao等.In vivo cancer targeting and imaging with semiconductor quantum dots.《Nature Biotechnology》.2004,969-976. * |
Also Published As
Publication number | Publication date |
---|---|
IL207839A0 (en) | 2010-12-30 |
WO2009106102A1 (de) | 2009-09-03 |
CN101977925A (zh) | 2011-02-16 |
ATE552268T1 (de) | 2012-04-15 |
JP2011514890A (ja) | 2011-05-12 |
HK1153211A1 (zh) | 2012-03-23 |
NZ587438A (en) | 2012-04-27 |
MX2010009526A (es) | 2010-11-26 |
AU2008351621A1 (en) | 2009-09-03 |
RU2010139903A (ru) | 2012-04-10 |
CA2716648A1 (en) | 2009-09-03 |
BRPI0822328A2 (pt) | 2015-07-14 |
US8796200B2 (en) | 2014-08-05 |
AU2008351621B2 (en) | 2013-05-09 |
KR20110007111A (ko) | 2011-01-21 |
JP5552437B2 (ja) | 2014-07-16 |
ES2392089T3 (es) | 2012-12-04 |
PL2250190T3 (pl) | 2012-11-30 |
DK2250190T3 (da) | 2012-07-16 |
EP2250190A1 (de) | 2010-11-17 |
KR101557982B1 (ko) | 2015-10-06 |
EP2250190B1 (de) | 2012-04-04 |
US20110110856A1 (en) | 2011-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Multifunctional magneto‐polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer | |
Colombo et al. | HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches | |
Ag et al. | Biofunctional quantum dots as fluorescence probe for cell-specific targeting | |
CN105899236B (zh) | 表现出改进的体内抗肿瘤活性的倍癌霉素adc | |
CN101360515B (zh) | 荧光纳米微粒 | |
Li et al. | Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer | |
KR20160102057A (ko) | Cd44 결합 펩티드 | |
Accardo et al. | Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells | |
CN104483296B (zh) | 乳腺癌分子探针及其制造方法 | |
Kwon et al. | In vitro and in vivo imaging of prostate cancer angiogenesis using anti-vascular endothelial growth factor receptor 2 antibody-conjugated quantum dot | |
Guan et al. | Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo | |
MX2012000086A (es) | Peptidos derivados de soricidi y metodos para la la deteccion de canceres trpv-6 y suministro de farmaco. | |
CN101977925B (zh) | 优化的粘附素片段及相应的纳米颗粒 | |
JP2015508747A (ja) | invivo光学イメージング、invivo多モード光学−MRIイメージング、および治療的診断のためのinsituで励起可能な持続的発光ナノ粒子 | |
Shi et al. | Quantum dots: emerging applications in urologic oncology | |
Zhang et al. | Nanobiotechnology: quantum dots in bioimaging | |
KR101405440B1 (ko) | 인테그린αvβ3에 특이적 압타머 및 이의 용도 | |
CN108136008A (zh) | 针对具有末端GlcNAcβ残基的肿瘤相关复合N-聚糖的抗体及其使用方法 | |
CN110448700B (zh) | 一种用于靶向诊疗胃癌的纳米载药复合物及制备方法 | |
KR101355985B1 (ko) | 다중 암 진단용 조성물 | |
KR101963147B1 (ko) | 1 나노몰 이하의 타겟 선택성을 갖는 정밀종양진단용 자기공명영상용 조영제 및 이의 제조방법 | |
DK2124880T3 (en) | Fluorescent nanoparticles | |
Chen et al. | Advances in the application of quantum dots in tumor markers investigation | |
Barton et al. | Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticles | |
Yin et al. | Fe3O4-Cy5. 5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1153211 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1153211 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: EXCHANGE IMAGING TECHNOLOGIES GMBH Free format text: FORMER OWNER: ENDOSIGNALS MEDIZINTECHNIK GMBH Effective date: 20150806 Owner name: ENDOSIGNALS IMAGING GMBH Free format text: FORMER OWNER: SIGNALOMICS GMBH Effective date: 20150806 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: ENDOSIGNALS MEDIZINTECHNIK GMBH Free format text: FORMER NAME: ENDOSIGNALS IMAGING GMBH |
|
CP01 | Change in the name or title of a patent holder |
Address after: Berlin Patentee after: Signal Medical Technology Co.,Ltd. Address before: Berlin Patentee before: Signal image Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150806 Address after: Darmstadt Patentee after: Interactie Image Technologies Ltd. Address before: Berlin Patentee before: Signal Medical Technology Co.,Ltd. Effective date of registration: 20150806 Address after: Berlin Patentee after: Signal image Co.,Ltd. Address before: Austria Vienna Patentee before: Signalomics GmbH |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141105 Termination date: 20180617 |
|
CF01 | Termination of patent right due to non-payment of annual fee |